Locus Bioscience
  • Platforms
  • Programs
  • Manufacturing
  • Careers
  • About Us
  • Newsroom
Contact

Newsroom

Learn more about us in our featured news stories and insights into our work

News Press Releases Locus Insights

Posts pagination

Prev 1 … 4 5 6 7 8 … 10 Next
  • January 8, 2020

    Locus Biosciences initiates world’s first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

    Learn More
  • December 3, 2019

    Locus CNBC Top 100

    Learn More
  • October 17, 2019

    Locus Co-founders Open Door to New CRISPR Systems

    Learn More
  • September 24, 2019

    Locus Makes FierceBiotech’s 2019 Fierce 15

    Learn More
  • July 5, 2019

    The Verge: These Superbug-Fighting Viruses are Making a Comeback

    Learn More
  • May 22, 2019

    NPR: Scientists Modify Viruses With CRISPR To Create New Weapon Against Superbugs

    Learn More
  • February 20, 2019

    Living Medicines: Engineering the Microbiome : SynBioBeta

    Learn More
  • January 16, 2019

    Wired: Antibiotics are Failing Us. CRISPR is Our Glimmer of Hope

    Learn More
  • January 9, 2019

    BioPharma Reporter: Janssen offers $818m to access CRISPR tech

    Learn More
  • January 4, 2019

    Microbiome Times: Locus Biosciences Enters Collaboration and License Agreement with J&J to Develop CRISPR-Cas3 Bacteriophage Therapeutics

    Learn More
  • Posts pagination

    Prev 1 … 3 4 5 6 7 8 9 10 Next

Media Inquiries


For all media inquiries, please contact
our public relations agency below

Contact Now
Locus Biosciences

Precision Medicines for Bacterial Infections
and Immunologic Diseases

Home

Platform

Programs

Manufacturing

Careers

About Us

Newsroom

Contact Us

Location

523 Davis Drive Suite 350
Morrisville NC 27560

Email

info@locus-bio.com

Linkedin

Linkedin

Twitter

Twitter

©Copyright 2025 Locus Biosciences, Inc. All rights reserved.

powered by wildfire